You are here : Home > News Archive > CARBOGEN AMCIS AG Adds Analytica...
CARBOGEN AMCIS AG Adds Analytical Enhancements

New Capabilities at Aarau and Bubendorf Facilities Benefit Customers

12 April 2007

BUBENDORF, Switzerland - The new CARBOGEN AMCIS AG High Containment Analytical Laboratory is commencing operations this month.  It has been designed to support analytics of Highly Potent compounds down to an OEL of 0.3ų g/m3 with staff wearing standard lab protective dress to provide a pleasant and safe working environment. The laboratory in-cludes nine easily cleanable hoods which house a range of analytical equipment to support the majority of standard processes.

CARBOGEN AMCIS has also added powder X-ray diffraction capability to its Aarau, Switzerland site. Powder X-ray technique provides an effective method of monitoring polymorphic proper-ties, an in-demand industry capability. 

“We have experienced increased requirements for the identification of morphic forms from our customers,” said Mark Griffiths, CEO, CARBOGEN AMCIS AG. “It is our objective to apply inno-vative chemistry solutions; the introduction of powder X-ray capabilities is an example of our flexibility and proactive attitude toward applying the best tools to achieve results for our cus-tomers.”

In addition, the Laboratory Information Management System (LIMS) has been introduced at the Bubendorf, Switzerland site. CARBOGEN AMCIS already has a fully compliant LIMS system op-erating at its Aarau and Hunzeschwil sites (both in Switzerland). The extension of the LIMS system to the Bubendorf site will mean that analytical data can be shared throughout the entire CARBOGEN AMCIS organization and directly with the customer in real time through secure por-tals at all sites.
“LIMS is a powerful and effective tool for our customers, providing improved management of laboratory data and allowing quick decision making,” said Griffiths. “LIMS allows CARBOGEN AMCIS to integrate and harmonize our lab processes and enables more effective scheduling of work and allocation of resources, including quality management, validation and regulatory compliance requirements.” 

CARBOGEN AMCIS AG is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development allowing customers to make the best use of available resources.

CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd., Ahmedabad, India.

Source: CARBOGEN AMCIS AG, Bubendorf, Switzerland

16 February 2018
CARBOGEN AMCIS Announces a Successful Swissmedic Inspection of its Site in Vionnaz, Switzerland

11 October 2017
CARBOGEN AMCIS Announces a Successful FDA Inspection of its Headquarters Site in Bubendorf, Switzerland

21 July 2017
CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection

DCAT week

World ADC Berlin